These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25640886)

  • 1. Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells.
    Pardanani A; Lasho T; Chen D; Kimlinger TK; Finke C; Zblewski D; Patnaik MM; Reichard KK; Rowinsky E; Hanson CA; Brooks C; Tefferi A
    Leukemia; 2015 Jul; 29(7):1605-8. PubMed ID: 25640886
    [No Abstract]   [Full Text] [Related]  

  • 2. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
    Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value.
    Pardanani A; Reichard KK; Zblewski D; Abdelrahman RA; Wassie EA; Morice Ii WG; Brooks C; Grogg KL; Hanson CA; Tefferi A; Chen D
    Leukemia; 2016 Apr; 30(4):914-8. PubMed ID: 26678095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in Allergy: Is a Bone Marrow Biopsy Optional or Essential in the Evaluation of the Patient with a Suspected Mast Cell Disorder?
    Greenberger PA; Metcalfe DD
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1134-1138. PubMed ID: 30630762
    [No Abstract]   [Full Text] [Related]  

  • 5. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.
    Akin C; Valent P; Escribano L
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):282-8. PubMed ID: 16822380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
    Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
    Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow.
    Guidolin D; Marinaccio C; Tortorella C; Ruggieri S; Rizzi A; Maiorano E; Specchia G; Ribatti D
    Exp Cell Res; 2015 Nov; 339(1):96-102. PubMed ID: 26358232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stromal composition of mast cell aggregates in systemic mastocytosis.
    Chiu A; Nanaji NM; Czader M; Gheorghe G; Knowles DM; Chadburn A; Orazi A
    Mod Pathol; 2009 Jul; 22(7):857-65. PubMed ID: 19396155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis.
    Atiakshin D; Buchwalow I; Horny P; Tiemann M
    Histochem Cell Biol; 2021 May; 155(5):561-580. PubMed ID: 33492488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
    Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
    Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood mastocytosis.
    Torrelo A; Alvarez-Twose I; Escribano L
    Curr Opin Pediatr; 2012 Aug; 24(4):480-6. PubMed ID: 22790101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
    Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
    Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition.
    Panda D; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Sardana R; Chaturvedi A; Rajpal S; Shetty D; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2021 May; 100(3):331-344. PubMed ID: 32738100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New views on systemic mastocytosis].
    Pluta A; Gutkowski K
    Pol Merkur Lekarski; 2003 Feb; 14(80):159-62. PubMed ID: 12728681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis.
    Baldus SE; Zirbes TK; Thiele J; Eming SA; Henz BM; Hartmann K
    Haematologica; 2004 Dec; 89(12):1525-7. PubMed ID: 15590405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.
    Teodosio C; García-Montero AC; Jara-Acevedo M; Sánchez-Muñoz L; Pedreira CE; Álvarez-Twose I; Matarraz S; Morgado JM; Bárcena P; Matito A; Mayado A; Sanchez ML; Diez-Campelo M; Escribano L; Orfao A
    J Allergy Clin Immunol; 2013 Apr; 131(4):1213-24, 1224.e1-4. PubMed ID: 23403045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia (AML-M2) with mast cell hyperplasia of bone marrow: a report of three cases.
    Adhya AK; Varma N; Varma S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):655-8. PubMed ID: 17883174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.